479 related articles for article (PubMed ID: 16295424)
1. Histomorphology of multiple myeloma on bone marrow biopsy.
Singhal N; Singh T; Singh ZN; Shome DK; Gaiha M
Indian J Pathol Microbiol; 2004 Jul; 47(3):359-63. PubMed ID: 16295424
[TBL] [Abstract][Full Text] [Related]
2. Significance of bone marrow fibrosis in multiple myeloma.
Subramanian R; Basu D; Dutta TK
Pathology; 2007 Oct; 39(5):512-5. PubMed ID: 17886102
[TBL] [Abstract][Full Text] [Related]
3. Bone marrow biopsy in multiple myeloma: a clinical pathological study.
Aghai E; Avni G; Lurie M; Quitt M; Hornstein L; Froom P
Isr J Med Sci; 1988 Jun; 24(6):298-301. PubMed ID: 3403226
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of bone marrow angiogenesis in multiple myeloma: use of light microscopy as well as computerized image analyzer in the assessment of microvessel density and total vascular area in multiple myeloma and its correlation with various clinical, histological, and laboratory parameters.
Bhatti SS; Kumar L; Dinda AK; Dawar R
Am J Hematol; 2006 Sep; 81(9):649-56. PubMed ID: 16845660
[TBL] [Abstract][Full Text] [Related]
5. Audit of bone marrow aspirates and trephine biopsies in multiple myeloma--a single centre study.
Charles KS; Winfield DA; Angel C; Goepel J
Clin Lab Haematol; 2004 Dec; 26(6):403-6. PubMed ID: 15595998
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic value of the ratio of bone marrow plasma cells in multiple myeloma].
Pasqualetti P; Colantonio D; Casale R
Minerva Med; 1990 Mar; 81(3):129-33. PubMed ID: 2320280
[TBL] [Abstract][Full Text] [Related]
7. Morphologic heterogeneity and plasmablastic transformation in advanced plasmacytic/plasmablastic myeloma: a study of 35 serial bone marrow biopsies in 9 patients.
Paule B; Quillard J; Bennet P; Mariette X; Bisson M
Nouv Rev Fr Hematol (1978); 1989; 31(3):203-8. PubMed ID: 2616267
[TBL] [Abstract][Full Text] [Related]
8. Bone marrow histological patterns in B-cell and T-cell prolymphocytic leukemia.
Nieto LH; Lampert IA; Catovsky D
Hematol Pathol; 1989; 3(2):79-84. PubMed ID: 2777734
[TBL] [Abstract][Full Text] [Related]
9. Role of MRI for the diagnosis and prognosis of multiple myeloma.
Baur-Melnyk A; Buhmann S; Dürr HR; Reiser M
Eur J Radiol; 2005 Jul; 55(1):56-63. PubMed ID: 15950101
[TBL] [Abstract][Full Text] [Related]
10. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of plasma cell morphology in multiple myeloma.
Paule B; Quillard J; Bisson M; Kahn MF; Massias P
Nouv Rev Fr Hematol (1978); 1988; 30(4):209-12. PubMed ID: 3194186
[TBL] [Abstract][Full Text] [Related]
12. Bone marrow infiltration pattern in B-cell chronic lymphocytic leukemia is related to immunoglobulin heavy-chain variable region mutation status and expression of 70-kd zeta-associated protein (ZAP-70).
Schade U; Bock O; Vornhusen S; Jäger A; Büsche G; Lehmann U; Kreipe H
Hum Pathol; 2006 Sep; 37(9):1153-61. PubMed ID: 16938520
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma with bone marrow biopsy features simulating concomitant chronic idiopathic myelofibrosis.
Schmidt U; Ruwe M; Leder LD
Nouv Rev Fr Hematol (1978); 1995; 37(2):159-63. PubMed ID: 7644355
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic application of sequential bone marrow biopsy in myeloma: analysis of 13 medullary biopsies].
Paule B; Médicis P; Clerc D; Bennet P; Bisson M; Massias P
Biomed Pharmacother; 1986; 40(7):261-4. PubMed ID: 3814757
[TBL] [Abstract][Full Text] [Related]
15. The prognostic impact of bone marrow involvement in patients with diffuse large cell lymphoma varies according to the degree of infiltration and presence of discordant marrow involvement.
Campbell J; Seymour JF; Matthews J; Wolf M; Stone J; Juneja S
Eur J Haematol; 2006 Jun; 76(6):473-80. PubMed ID: 16529599
[TBL] [Abstract][Full Text] [Related]
16. Lymphoproliferative disorders in the bone marrow: histologic criteria for classification and staging.
Bartl R; Frisch B; Hoffmann-Fezer G; Burkhardt R
Haematologia (Budap); 1984; 17(2):227-46. PubMed ID: 6534830
[TBL] [Abstract][Full Text] [Related]
17. A review of the cytokine network in multiple myeloma: diagnostic, prognostic, and therapeutic implications.
Lauta VM
Cancer; 2003 May; 97(10):2440-52. PubMed ID: 12733143
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow angiogenesis in multiple myeloma and its correlation with clinicopathological factors.
Rana C; Sharma S; Agrawal V; Singh U
Ann Hematol; 2010 Aug; 89(8):789-94. PubMed ID: 20177896
[TBL] [Abstract][Full Text] [Related]
19. Assessment of bone marrow fibrosis and angiogenesis in monitoring patients with multiple myeloma.
Babarović E; Valković T; Štifter S; Budisavljević I; Seili-Bekafigo I; Duletić-Načinović A; Lučin K; Jonjić N
Am J Clin Pathol; 2012 Jun; 137(6):870-8. PubMed ID: 22586045
[TBL] [Abstract][Full Text] [Related]
20. [Correlation of MRI and histopathology of bone marrow in patients with multiple myeloma].
Wasser K; Moehler T; Nosas-Garcia S; Rehm C; Bartl R; Goldschmidt H; Düber C; Kauczor HU; Delorme S
Rofo; 2005 Aug; 177(8):1116-22. PubMed ID: 16021544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
